Humane Society of Southern Wisconsin competitors

Mark is a student INSTITUTE OF DIRECTORS starting in 2021 and is based in London, Greater London, United Kingdom. He is a Chief Executive STEP at STEP. Mark has worked as Regional Director at Cohen Brown Europe; Regional Managing Director, EMEA at RICS; and Director of Corporate Education at THE LONDON INSTITUTE OF BANKING & FINANCE. He attended Alliance Manchester Business School, Windsor Grammar School between 1974 and 1981, and INSTITUTE OF DIRECTORS between 2012 and 2012.

Entrepreneur of Milwaukee Heart Service/ R & M Medical/ Life Support Systems, Inc., 38 years of Cardiovascular Medicine, Worked with world Renowned Heart Surgeon W. Dudley Johnson MD, Creator & Pioneer of several invasive and non invasive services throughout the country. Was the first in the USA to put a Jarvick artificial heart. Personally built Cardiac Cath labs throughout the Mid West. First to transport patient on bi-vad, Responsible for creating Flight For Life out of Milwaukee WI. Specialties: Cardiovascular Medicine-Non Invasive & Invasive/ Entrepreneur Business Owner

Mitch Betses is the Chief Operating Officer at Haven. Prior to that, he was the Executive Vice President and Chief Operating Officer of Beacon Health Options.

Dr. Wenyuan Shi was appointed Chief Executive Officer and Chief Scientific Officer of the Forsyth Institute on September 1, 2017. Before his appointment, Shi was a chairman and professor of Oral Biology at UCLA Schools of Dentistry. Shi’s laboratory has been using multidisciplinary approaches to study oral microbial pathogenesis with a specific focus on microbial biofilm, inter-species interaction and signal transduction. In addition, Shi’s laboratory is actively involved in the development of next generation diagnostic and therapeutic tools against oral microbial infections, including instant chairside detection of oral pathogens and peptide-based targeted antimicrobial therapeutics. These translational research efforts have resulted in novel technologies that are licensed and developed by major pharmaceutical, dental and biotech companies. Shi is also the founding scientist, chief scientific officer and chairman of the scientific advisory board of C3J Therapeutics Inc. Shi obtained his BS degree from Fudan University in Shanghai in 1984, acquired his PhD degree from the University of Wisconsin-Madison in 1991 and fulfilled his postdoctoral training at the University of California-Berkeley from 1992-1995. He is the co-author of over 200 scientific articles and is credited as co-inventor of 45 patents.